Ergoteles LLC Moderna, Inc. Transaction History

Ergoteles LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$126.46 - $235.05 $101,294 - $188,275	-801 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $2.65 Million - $4.32 Million	-11,735 Reduced 93.61%	801 $203,000
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $6.73 Million - $14.7 Million	-30,313 Reduced 70.74%	12,536 $4.83 Million
Q2 2021 Aug 12, 2021	BUY	$129.91 - $234.98 $5.57 Million - $10.1 Million	42,849 New	42,849 $10.1 Million
Q1 2021 May 12, 2021	SELL	$109.18 - $185.98 $5.14 Million - $8.76 Million	-47,108 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$65.74 - $169.86 $3.1 Million - $8 Million	47,108 New	47,108 $4.92 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.